Geode Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159M | Buy |
|
|||||
|
2025
Q1 | $121M | Buy |
|
|||||
|
2024
Q4 | $93.8M | Buy |
|
|||||
|
2024
Q3 | $86.9M | Buy |
|
|||||
|
2024
Q2 | $83.4M | Buy |
|
|||||
|
2024
Q1 | $88.5M | Buy |
|
|||||
|
2023
Q4 | $110M | Buy |
|
|||||
|
2023
Q3 | $66.2M | Buy |
|
|||||
|
2023
Q2 | $41.6M | Buy |
|
|||||
|
2023
Q1 | $37.4M | Buy |
|
|||||
|
2022
Q4 | $15.7M | Buy |
|
|||||
|
2022
Q3 | $19.5M | Sell |
|
|||||
|
2022
Q2 | $17.9M | Buy |
|
|||||
|
2022
Q1 | $18.1M | Sell |
|
|||||
|
2021
Q4 | $32.1M | Sell |
|
|||||
|
2021
Q3 | $91.3M | Buy |
|
|||||
|
2021
Q2 | $111M | Buy |
|
|||||
|
2021
Q1 | $102M | Buy |
|
|||||
|
2020
Q4 | $86M | Buy |
|
|||||
|
2020
Q3 | $43.5M | Buy |
|
|||||
|
2020
Q2 | $23.9M | Buy |
|
|||||
|
2020
Q1 | $21M | Buy |
|
|||||
|
2019
Q4 | $12.2M | Buy |
|
|||||
|
2019
Q3 | $7.2M | Buy |
|